Wilms' tumor protein (WT1) in mammary myofibroblastoma: An immunohistochemical study

Acta Histochemica

Volumn 116, Issue 5, 2014, Pages 905-910

  Magro, Gaetano ^a   Longo, Francesca ^a   Salvatorelli, Lucia ^a   Vecchio, Giada Maria ^a   Parenti, Rosalba ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Breast; Cytoplasmic immunostaining; Epithelioid variant; Myofibroblastoma; Wilms' tumor; WT1

Indexed keywords

WT1 PROTEIN;

ARTICLE; BLASTOMA; CANCER CELL; CELL SHAPE; CYTOPLASM; ENDOTHELIUM CELL; EPITHELIOID CELL; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAMMARY MYOFIBROBLASTOMA; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPINDLE CELL; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUSCLE TUMOR; PATHOPHYSIOLOGY;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS, MUSCLE TISSUE; WT1 PROTEINS;

EID: 84904053660     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2014.03.001     Document Type: Article

References (60)

1. Al Dhaybi R., Powell J., McCuaig C., Kokta V. Differentiation of vascular tumors from vascular malformations by expression of Wilms' tumor 1 gene: evaluation of 126 cases. J Am Acad Dermatol 2010, 63:1052-1057.
2. Armstrong J.F., Pritchard-Jones K., Bickmore W.A., Hastie N.D., Bard J.B. The expression of the Wilms' tumour gene WT1 in the developing mammalian embryo. Mech Dev 1993, 40:85-97.
3. Bisceglia M., Vairo M., Galliani C., Lastilla G., Parafioriti A., DeMaglio G., et al. Immunohistochemical investigation of WT1 expression in 117 embryonal tumors. Pathologica 2011, 103:182-183.
4. Call K.M., Glaser T., Ito C.Y., Buckler A.J., Pelletier J., Haber D.A., et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 1990, 60:509-520.
5. Carpentieri D.F., Nichols K., Chou P.M., Matthews M., Pawel B., Huff D. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors. Mod Pathol 2002, 15:1080-1086.
6. Charles A.K., Mall S., Watson J., Berry P.J. Expression of the Wilms' tumour gene WT1 in the developing human and in paediatric renal tumours: an immunohistochemical study. Mol Pathol 1997, 50:138-144.
7. Gessler M., Poustka A., Cavenee W., Neve R.L., Orkin S.H., Burns G.A. Homozygous deletion in Wilms' tumours of a zincfinger gene identified by chromosome jumping. Nature (Lond) 1990, 343:774-778.
8. Hartkamp J., Roberts S.G. The role of the Wilms' tumour-suppressor protein WT1 in apoptosis. Biochem Soc Trans 2008, 36:629-631.
9. Herzer U., Crocoll A., Barton D., Howells N., Englert C. The Wilms' tumor suppressor gene WT1 is required for development of the spleen. Curr Biol 1999, 9:837-840.
10. Hohenstein P., Hastie N.D. The many facets of the Wilms' tumour gene, WT1. Hum Mol Genet 2006, 15(Spec. No. 2):R196-R201.
11. Huff V. Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene. Nat Rev Cancer 2011, 11:111-121.
12. Kent J., Coriat A.M., Sharpe P.T., Hastie N.D., van Heyningen V. The evolution of WT1 sequence and expression pattern in the vertebrates. Oncogene 1995, 11:1781-1792.
13. Kumar-Singh S., Segers K., Rodeck U., Backhovens H., Bogers J., Weyler J., et al. WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis. J Pathol 1997, 181:67-74.
14. Lawley L.P., Cerimele F., Weiss S.W., North P., Cohen C., Kozakewich H.P., et al. Expression of Wilms' tumor 1 gene distinguishes vascular malformations from proliferative endothelial lesions. Arch Dermatol 2005, 141:1297-1300.
15. Lee S.B., Haber D.A. Wilms' tumor and the WT1 gene. Exp Cell Res 2001, 264:74-99.
16. Loke S.L., Neckers L.M., Schwab G., Jaffe E.S. c-Myc protein in normal tissue. Effects of fixation on its apparent subcellular distribution. Am J Pathol 1988, 131:29-37.
17. Maggiani F., Debiec-Rychter M., Verbeeck G., Sciot R. Extramammary myofibroblastoma is genetically related to spindle cell lipoma. Virchows Arch 2006, 449:244-247.
18. Maggiani F., Debiec-Rychter M., Vanbockrijck M., Sciot R. Cellular angiofibroma: another mesenchymal tumour with 13q14 involvement, suggesting a link with spindle cell lipoma and (extra)-mammary myofibroblastoma. Histopathology 2007, 51:410-412.
19. Magro G., Bisceglia M., Pasquinelli G. Benign spindle cell tumor of the breast with prominent adipocytic component. Ann Diagn Pathol 1998, 2:306-311.
20. Magro G., Fraggetta F., Torrisi A., Emmanuele C., Lanzafame S. Myofibroblastoma of the breast with haemagiopericytoma-like pattern and pleomorphic lipoma-like areas. Pathol Res Pract 1999, 195:257-262.
21. Magro G., Michal M., Vasquez E., Bisceglia M. Lipomatous myofibroblastoma: a potential diagnostic pitfall in the spectrum of the spindle cell lesions of the breast. Virchows Arch 2000, 437:540-544.
22. Magro G., Michal M., Bisceglia M. Benign spindle cell tumors of the mammary stroma: diagnostic criteria, classification, and histogenesis. Pathol Res Pract 2001, 197:453-466.
23. Magro G., Bisceglia M., Michal M., Eusebi V. Spindle cell lipoma-like tumor, solitary fibrous tumor and myofibroblastoma of the breast: a clinicopathological analysis of 13 cases in favor of a unifying histologic concept. Virchows Arch 2002, 440:249-260.
24. Magro G., Gurrera A., Bisceglia M. H-caldesmon expression in myofibroblastoma of the breast: evidence supporting the distinction from leiomyoma. Histopathology 2003, 42:233-238.
25. Magro G., Gangemi P., Villari L., Greco P. Deciduoid-like stromal cells in a diabetic patient with bilateral gynecomastia: a potential diagnostic pitfall. Virchows Arch 2004, 445:659-660.
26. Magro G., Bisceglia M. Myofibroblastoma-like changes in fibro(stromo)-epithelial lesions of the breast: report of two cases. Virchows Arch 2005, 446:95-96.
27. Magro G., Caltabiano R., Di Cataldo A., Puzzo L. CD10 is expressed by mammary myofibroblastoma and spindle cell lipoma of soft tissue: an additional evidence of their histogenetic linking. Virchows Arch 2007, 450:727-728.
28. Magro G. Stromal tumors of the lower female genital tract: histogenetic, morphological and immunohistochemical similarities with the "benign spindle cell tumors of the mammary stroma". Pathol Res Pract 2007, 203:827-829.
29. Magro G., Amico P., Gurrera A. Myxoid myofibroblastoma of the breast with atypical cells: a potential diagnostic pitfall. Virchows Arch 2007, 450:483-485.
30. Magro G., Gangemi P., Greco P. Deciduoid-like myofibroblastoma of the breast: a potential pitfall of malignancy. Histopathology 2008, 52:652-654.
31. Magro G. Mammary myofibroblastoma: a tumor with a wide morphologic spectrum. Arch Pathol Lab Med 2008, 132:1813-1820.
32. Magro G. Epithelioid-cell myofibroblastoma of the breast. Expanding the morphologic spectrum. Am J Surg Pathol 2009, 33:1085-1092.
33. Magro G. Epithelioid cell myofibroblastoma of the breast. A potential diagnostic pitfall. Breast 2012, 18:278-279.
34. Magro G., Caltabiano R., Kacerovská D., Vecchio G.M., Kazakov D., Michal M. Vulvovaginal myofibroblastoma: expanding the morphological and immunohistochemical spectrum. A clinicopathologic study of 10 cases. Hum Pathol 2012, 43:243-253.
35. Magro G., Righi A., Casorzo L., Torrisi L.A., Salvatorelli L., Kacerovská D., et al. Mammary and vaginal myofibroblastomas are genetically related lesions: fluorescence in situ hybridization analysis shows deletion of 13q14 region. Hum Pathol 2012, 43:1887-1893.
36. Magro G., Foschini M.P., Eusebi V. Palisaded myofibroblastoma of the breast: a tumor closely mimicking schwannoma. Report of two cases. Hum Pathol 2013, 44:1941-1946.
37. Magro G., Vecchio G.M., Michal M., Eusebi E. Atypical epithelioid cell myofibroblastoma of the breast with multinodular growth pattern: a potential pitfall of malignancy. Pathol Res Pract 2013, 209:463-466.
38. McMenamin M.E., Fletcher C.D.M. Mammary-type myofibroblastoma of soft tissue: a tumor closely related to spindle cell lipoma. Am J Surg Pathol 2001, 25:1022-1029.
39. Menke A.L., van der Eb A.J., Jochemsen A.G. The Wilms' tumor 1 gene: oncogene or tumor suppressor gene?. Int Rev Cytol 1998, 181:151-212.
40. Moore A.W., McInnes L., Kreidberg J., Hastie N.D., Schedl A. YAC complementation shows a requirement for WT1 in the development of epicardium, adrenal gland and throughout nephrogenesis. Development 1999, 126:1845-1857.
41. Mundlos S., Pelletier J., Darveau A., Bachmann M., Winterpacht A., Zabel B. Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues. Development 1993, 119:1329-1341.
42. Nakatsuka S., Oji Y., Horiuchi T., Kanda T., Kitagawa M., Takeuchi T., et al. Immunohistochemical detection of WT1 protein in a variety of cancer cells. Mod Pathol 2006, 19:804-814.
43. Parenti R., Perris R., Vecchio G.M., Salvatorelli L., Torrisi A., Gravina L., et al. Immunohistochemical expression of Wilms' tumor protein (WT1) in developing human epithelial and mesenchymal tissues. Acta Histochem 2013, 115:70-75.
44. Parenti R., Puzzo L., Vecchio G.M., Gravina L., Salvatorelli L., Musumeci G., et al. Immunolocalization of Wilms' Tumor protein (WT1) in developing human peripheral sympathetic and gastroenteric nervous system. Acta Histochem 2013, [Epub ahead of print]. 10.1016/j.acthis.2013.05.003.
45. Pritchard-Jones K., Fleming S., Davidson E.C., Bickmore W., Porteus D.J., Gosden C., et al. The candidate Wilms' tumor gene is involved in genitourinary development. Nature (Lond) 1990, 346:194-197.
46. Rackley R.R., Flenniken A.M., Kuriyan N.P., Kessler P.M., Stoler M.H., Williams B.R. Expression of the Wilms' tumor suppressor gene WT1 during mouse embryogenesis. Cell Growth Differ 1993, 4:1023-1031.
47. Ramani P., Cowell J.K. The expression pattern of Wilms' tumour gene (WT1) product in normal tissues and paediatric renal tumours. J Pathol 1996, 179:162-168.
48. Royds J.A., Sharrard R.M., Wagner B., Polacarz S.V. Cellular localization of c-myc product in human colorectal epithelial neoplasia. J Pathol 1992, 166:225-233.
49. Salvatorelli L., Bisceglia M., Vecchio G., Parenti R., Galliani C., Alaggio R. A comparative immunohistochemical study of oncofetal cytoplasmic WT1 expression in human fetal, adult and neoplastic skeletal muscle. Pathologica 2011, 103:186.
50. Scholz H., Kirschner K.M. A role for the Wilms' tumor protein WT1 in organ development. Physiology (Bethesda) 2005, 20:54-59.
51. Schittenhelm J., Thiericke J., Nagel C., Meyermann R., Beschorner R. WT1 expression in normal and neoplastic cranial and peripheral nerves is independent of grade malignancy. Cancer Biomark 2010, 7:73-77.
52. Sharma P.M., Yang X., Bowman M., Roberts V., Sukumar S. Molecular cloning of rat Wilms' tumor complementary DNA and a study of messenger RNA expression in the urogenital system and the brain. Cancer Res 1992, 52:6407-6412.
53. Shimizu M., Toki T., Takagi Y., Konishi I., Fujii S. Immunohistochemical detection of the Wilms' tumor gene (WT1) in epithelial ovarian tumors. Int J Gynecol Pathol 2000, 19:158-163.
54. Singh A., Mishra A.K., Ylaya K., Hewitt S.M., Sharma K.C., Saxena S. Wilms tumor-1, claudin-1 and ezrin are useful immunohistochemical markers that help to distinguish schwannoma from fibroblastic meningioma. Pathol Oncol Res 2012, 18:383-389.
55. Timár J., Mészáros L., Orosz Z., Albini A., Rásó E. WT1 expression in angiogenic tumours of the skin. Histopathology 2005, 47:67-73.
56. Trindade F., Tellechea O., Torrelo A., Requena L., Colmenero I. Wilms' tumor 1 expression in vascular neoplasms and vascular malformations. Am J Dermatopathol 2011, 33:569-572.
57. Tsuta K., Kato Y., Tochigi N., Hoshino T., Takeda Y., Hosako M., et al. Comparison of different clones (WT49 versus 6F-H2) of WT-1 antibodies for immunohistochemical diagnosis of malignant pleural mesothelioma. Appl Immunohistochem Mol Morphol 2009, 17:126-130.
58. Vecchio G.M., Greco P., Longo F., Alaggio R., Amico P., Sabino F., et al. Cytoplamsic expression of WT1 in peditaric soft tissue fibro-myofibroblastic tumor and tumor-like lesions. Pathologica 2011, 103:165.
59. Zhang P.J., Goldblum J.R., Pawel B.R., Fisher C., Pasha T.L., Barr F.G. Immunophenotype of desmoplastic small round cell tumors as detected in cases with EWS-WT1 gene fusion product. Mod Pathol 2003, 16:229-235.
60. Zhao C., Bratthauer G.L., Barner R., Vang R. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor. Am J Surg Pathol 2007, 31:1378-1386.